SUMO1 Modification Facilitates Avibirnavirus Replication by Stabilizing Polymerase VP1.


Journal

Journal of virology
ISSN: 1098-5514
Titre abrégé: J Virol
Pays: United States
ID NLM: 0113724

Informations de publication

Date de publication:
15 05 2019
Historique:
received: 12 12 2018
accepted: 23 02 2019
pubmed: 8 3 2019
medline: 3 3 2020
entrez: 8 3 2019
Statut: epublish

Résumé

SUMOylation is a posttranslational modification that has crucial roles in diverse cellular biological pathways and in various viral life cycles. In this study, we found that the VP1 protein, the RNA-dependent RNA polymerase of avibirnavirus infectious bursal disease virus (IBDV), regulates virus replication by SUMOylation during infection. Our data demonstrated that the polymerase VP1 is efficiently modified by small ubiquitin-like modifier 1 (SUMO1) in avibirnavirus-infected cell lines. Mutation analysis showed that residues

Identifiants

pubmed: 30842328
pii: JVI.02227-18
doi: 10.1128/JVI.02227-18
pmc: PMC6498067
pii:
doi:

Substances chimiques

SUMO-1 Protein 0
SUMO1 protein, human 0
VP1 protein, infectious bursal disease virus 0
Viral Proteins 0
Viral Structural Proteins 0
RNA-Dependent RNA Polymerase EC 2.7.7.48

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2019 American Society for Microbiology.

Références

J Virol. 2019 Jan 17;93(3):
pubmed: 30429342
Nat Rev Microbiol. 2013 Jun;11(6):400-11
pubmed: 23624814
PLoS One. 2015 Jun 05;10(6):e0128828
pubmed: 26046798
J Virol. 2013 Apr;87(8):4704-15
pubmed: 23365455
Nat Rev Mol Cell Biol. 2015 May;16(5):322-4
pubmed: 25907614
J Gen Virol. 1995 Feb;76 ( Pt 2):437-43
pubmed: 7844565
Virus Res. 2011 Jun;158(1-2):12-27
pubmed: 21376763
Immunity. 2016 Sep 20;45(3):555-569
pubmed: 27637147
J Virol. 2014 Oct;88(19):11154-65
pubmed: 25031338
Autophagy. 2015;11(3):503-15
pubmed: 25714412
Nat Rev Mol Cell Biol. 2010 Dec;11(12):861-71
pubmed: 21102611
Nat Commun. 2013;4:1850
pubmed: 23673635
Oncogene. 2014 Aug 21;33(34):4316-29
pubmed: 24362530
Nat Commun. 2012 Jun 19;3:911
pubmed: 22713753
PLoS Pathog. 2015 Mar 12;11(3):e1004726
pubmed: 25763818
J Virol. 2001 Nov;75(22):10815-28
pubmed: 11602723
Mol Immunol. 2009 Jun;46(10):1964-9
pubmed: 19361862
Mol Cell. 2006 Nov 3;24(3):341-54
pubmed: 17081986
J Gen Virol. 2004 Aug;85(Pt 8):2221-2229
pubmed: 15269362
J Virol. 2016 Nov 14;90(23):10472-10485
pubmed: 27630238
J Mol Cell Biol. 2011 Oct;3(5):283-92
pubmed: 22028379
Nat Commun. 2015 Nov 19;6:8899
pubmed: 26582366
DNA Cell Biol. 2006 Nov;25(11):646-53
pubmed: 17132096
J Virol. 2015 Nov;89(21):11165-8
pubmed: 26311889
Nat Rev Mol Cell Biol. 2012 Dec;13(12):755-66
pubmed: 23175280
J Biol Chem. 2006 Jun 9;281(23):16117-27
pubmed: 16524884
Nat Struct Mol Biol. 2014 Oct;21(10):927-36
pubmed: 25218447
Nat Commun. 2014 Jun 23;5:4234
pubmed: 24953629
J Virol. 2010 Jan;84(2):918-27
pubmed: 19889771
Mol Cell Proteomics. 2008 Mar;7(3):612-25
pubmed: 18056921
Nat Commun. 2015 Nov 24;6:8917
pubmed: 26596471
J Virol. 2016 Apr 14;90(9):4308-4319
pubmed: 26889037
J Virol. 2005 Oct;79(19):12253-63
pubmed: 16160151
J Virol. 2005 Jan;79(2):910-7
pubmed: 15613319
Proc Natl Acad Sci U S A. 2007 May 1;104(18):7385-90
pubmed: 17456597
J Virol. 2002 Mar;76(5):2393-402
pubmed: 11836417
Nat Commun. 2017 Jun 01;8:15426
pubmed: 28569748
J Virol. 2015 Mar;89(5):2777-91
pubmed: 25540360
Proc Natl Acad Sci U S A. 2007 Dec 18;104(51):20540-5
pubmed: 18077388
Nat Struct Mol Biol. 2013 Apr;20(4):525-31
pubmed: 23503365
J Virol. 2014 Aug;88(16):9379-90
pubmed: 24920808
Virology. 2009 Dec 5;395(1):87-96
pubmed: 19801157

Auteurs

Huansheng Wu (H)

MOA Key Laboratory of Animal Virology, Department of Veterinary Medicine, Zhejiang University, Hangzhou, China.

Hui Yang (H)

MOA Key Laboratory of Animal Virology, Department of Veterinary Medicine, Zhejiang University, Hangzhou, China.

Gang Ji (G)

Institute of Immunology, Nanjing Agricultural University, Nanjing, China.

Tuyuan Zheng (T)

Institute of Immunology, Nanjing Agricultural University, Nanjing, China.

Yina Zhang (Y)

MOA Key Laboratory of Animal Virology, Department of Veterinary Medicine, Zhejiang University, Hangzhou, China.

Tingjuan Deng (T)

MOA Key Laboratory of Animal Virology, Department of Veterinary Medicine, Zhejiang University, Hangzhou, China.

Xiaojuan Zheng (X)

MOA Key Laboratory of Animal Virology, Department of Veterinary Medicine, Zhejiang University, Hangzhou, China.

Jiyong Zhou (J)

MOA Key Laboratory of Animal Virology, Department of Veterinary Medicine, Zhejiang University, Hangzhou, China jyzhou@zju.edu.cn bolihu28@126.com.
Collaborative Innovation Center and State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, First Affiliated Hospital, Zhejiang University, Hangzhou, China.

Boli Hu (B)

MOA Key Laboratory of Animal Virology, Department of Veterinary Medicine, Zhejiang University, Hangzhou, China jyzhou@zju.edu.cn bolihu28@126.com.
Institute of Immunology, Nanjing Agricultural University, Nanjing, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH